38767 studies found for:    Open Studies | Senior
Show Display Options
Rank Status Study
21 Recruiting A Trial of Incentives and Peer Mentors to Improve Diabetic Outcomes
Condition: Diabetes Mellitus
Interventions: Behavioral: Incentives;   Behavioral: Education;   Behavioral: Peer mentoring
22 Recruiting Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Conditions: Hematopoietic Stem Cell Transplantation;   Solid Tumor;   Transplantation, Autologous
Interventions: Drug: Ifosfamide;   Drug: Etoposide phosphate;   Drug: Mesna;   Biological: Granulocyte colony-stimulating factor;   Drug: Busulfan;   Drug: Melphalan;   Drug: Thiotepa;   Biological: Autologous stem cell infusion;   Radiation: Radiation;   Drug: Caboplatin
23 Unknown  Hyperimmune Colostrum and Oral Mucositis
Condition: Head and Neck Cancer
Interventions: Dietary Supplement: hyperimmune colostrum;   Dietary Supplement: Placebo
24 Unknown  Paclitaxel/Carboplatin With or Without Cetuximab in CUP
Conditions: Neoplasms, Unknown Primary;   Carcinoma
Interventions: Drug: paclitaxel/carboplatin;   Drug: cetuximab
25 Recruiting Multi-Centre Trial of Fresh vs. Frozen-and-Thawed HBT(Fecal Transplant)for Recurrent CDI
Condition: Clostridium Difficile Infection
Interventions: Procedure: Fresh Human Biotherapy;   Procedure: Frozen-and-Thawed Human Biotherapy
26 Not yet recruiting E-Selectin Nasal Instillation to Prevent Secondary Stroke
Conditions: Ischemic Attack, Transient;   Transient
Intervention: Drug: Intransal instillation of E-selectin
27 Unknown  Efficacy Study of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Drug: IZN-6D4 Gel;   Other: Placebo hydrogel
28 Recruiting Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: irinotecan, oxaliplatin and cetuximab
29 Recruiting Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
Condition: Graft Versus Host Disease
Intervention: Drug: Ibrutinib
30 Unknown  Treatment of Chronic GVHD of Liver or Lungs by ECP
Condition: Chronic Graft-Versus Host Disease
Intervention: Procedure: Extracorporeal photoimmunotherapy
31 Unknown  Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
Conditions: Hepatitis B, Chronic;   Hepatitis C, Chronic
Intervention: Drug: Peginterferon Alfa-2a plus Ribavirin
32 Unknown  Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia
Conditions: Dystonia;   Movement Disorder
Intervention: Procedure: deep brain stimulation
33 Not yet recruiting Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders
Conditions: Depression;   Bipolar Disorders;   Mood Disorders
34 Recruiting Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B
Condition: Chronic Hepatitis B
35 Recruiting A Multi Center, Study to Evaluate the Safety and Efficacy of the Laminate External Support Device for Arteriovenous Fistulas
Condition: Vascular Access
Intervention: Device: Laminate External Support
36 Recruiting Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Xeloda
37 Recruiting Immunotherapy in Subjects With HPV6 (Human Papillomavirus) Associated Aerodigestive Malignancies
Condition: Aerodigestive Malignancies (e.g Squamous Cell Carcinoma)
Intervention: Biological: INO-3106, INO-9012
38 Recruiting Determine the Haemostatic Efficacy of TT-173, Reducing the Bleeding Time in the Donor Site of Skin Grafting
Conditions: Burns;   Traumatic Lesions
Interventions: Drug: TT-173;   Drug: Placebo
39 Recruiting Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer
Condition: Cancer
Interventions: Drug: REGN1400;   Drug: Erlotinib;   Drug: Cetuximab
40 Recruiting A Study of Selumetinib in Patients With Kaposi's Sarcoma
Condition: AIDS-related Kaposi's Sarcoma
Intervention: Drug: Selumetinib

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years